Aprea Therapeutics, Inc. (APRE)
USD 3.08
(-7.78%)
USD 3.08
(-7.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 583.23 Thousand | - | - | - | - | - |
| Cost of Revenue | 7052.00 | 186.44 Thousand | 271.67 Thousand | 229.61 Thousand | 170.25 Thousand | 8316.00 |
| Gross Profit | 576.17 Thousand | -186.44 Thousand | -271.67 Thousand | -229.61 Thousand | -170.25 Thousand | -8316.00 |
| Operating Expenses | 16.04 Million | 37.37 Million | 37.44 Million | 52.81 Million | 29.54 Million | 16.48 Million |
| Selling, General and Administrative Expenses | 8.42 Million | 20.96 Million | 13.55 Million | 14.93 Million | 8.59 Million | 2.29 Million |
| Research and Development Expenses | 7.62 Million | 16.4 Million | 23.89 Million | 37.87 Million | 20.95 Million | 14.19 Million |
| Other Expenses | - | 76.02 Million | - | - | - | - |
| Cost and Expenses | 16.05 Million | 37.37 Million | 37.44 Million | 52.81 Million | 29.54 Million | 16.48 Million |
| Operating Income | -15.47 Million | 38.18 Million | -38.03 Million | -52.15 Million | -31.04 Million | -16.48 Million |
| Interest Expense | - | 448.66 Thousand | - | 222.65 Thousand | 156.35 Thousand | 182.00 |
| Income Tax Expense | - | 112.21 Million | -590.72 Thousand | 437.99 Thousand | -1.65 Million | 961.31 Thousand |
| Earnings before Tax | -14.28 Million | -112.66 Million | -37.12 Million | -53.47 Million | -28.05 Million | -15.52 Million |
| Net Income | -14.28 Million | -224.87 Million | -36.53 Million | -53.91 Million | -26.4 Million | -15.52 Million |
| Earnings Per Share Basic | -3.95 | -2714.18 | -34.33 | -51.02 | -26.28 | -22.06 |
| Earnings Per Share Diluted | -3.95 | -2714.18 | -34.33 | -51.02 | -26.28 | -22.06 |
| Weighted Average Shares Outstanding | 3.61 Million | 82.85 Thousand | 1.06 Million | 1.05 Million | 1 Million | 703.78 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.61 Million | 82.85 Thousand | 1.06 Million | 1.05 Million | 1 Million | 703.78 Thousand |
| Gross Margin | 0.99 | - | - | - | - | - |
| EBIT Margin | -24.48 | - | - | - | - | - |
| Profit Margin | -24.50 | - | - | - | - | - |
| EBITDA | -14.27 Million | -112.47 Million | -36.85 Million | -53.24 Million | -27.88 Million | -15.51 Million |
| Earnings Before Tax Margin | -26.53 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 561.57 Thousand | 380.56 Thousand | 14.07 Thousand | 583.23 Thousand | 319.46 Thousand | 249.68 Thousand |
| Cost of Revenue | 5304.00 | 6157.00 | 4986.00 | 7052.00 | - | - |
| Gross Profit | 556.26 Thousand | 374.41 Thousand | 9089.00 | 576.17 Thousand | 319.46 Thousand | 249.68 Thousand |
| Operating Expenses | 4.4 Million | 3.52 Million | 3.68 Million | 16.04 Million | 3.52 Million | 3.65 Million |
| Selling, General and Administrative Expenses | 1.84 Million | 1.92 Million | 1.63 Million | - | 1.71 Million | 1.69 Million |
| Research and Development Expenses | 2.55 Million | 1.6 Million | 2.04 Million | - | 2.12 Million | 2.2 Million |
| Other Expenses | -561.57 Thousand | - | - | - | - | - |
| Cost and Expenses | 4.4 Million | 3.53 Million | 3.68 Million | 16.05 Million | 3.52 Million | 3.65 Million |
| Operating Income | -3.84 Million | -3.14 Million | -3.67 Million | -15.47 Million | -3.52 Million | -3.65 Million |
| Interest Expense | - | - | 229.22 Thousand | - | - | - |
| Income Tax Expense | -5.00 | 2.00 | 4.00 | -2.00 | -318.33 Thousand | -392.58 Thousand |
| Earnings before Tax | -3.47 Million | -2.81 Million | -3.44 Million | -14.28 Million | -3.2 Million | -3.25 Million |
| Net Income | -3.47 Million | -2.81 Million | -3.44 Million | -14.28 Million | -3.2 Million | -3.25 Million |
| Earnings Per Share Basic | -0.58 | -0.67 | -0.92 | - | -0.86 | -0.87 |
| Earnings Per Share Diluted | -0.58 | -0.67 | -0.92 | - | -0.86 | -0.87 |
| Weighted Average Shares Outstanding | 5.93 Million | 4.19 Million | 3.73 Million | 3.61 Million | 3.73 Million | 3.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.93 Million | 4.19 Million | 3.73 Million | 3.61 Million | 3.73 Million | 3.73 Million |
| Gross Margin | 0.99 | 0.98 | 0.65 | 0.99 | 1.00 | 1.00 |
| EBIT Margin | -6.84 | -8.26 | -260.74 | - | -11.01 | -14.85 |
| Profit Margin | -6.18 | -7.38 | -244.64 | -24.50 | -10.03 | -13.05 |
| EBITDA | -3.84 Million | -3.14 Million | -3.66 Million | - | -3.51 Million | -3.7 Million |
| Earnings Before Tax Margin | -6.85 | -8.28 | -261.10 | -26.53 | -11.03 | -14.62 |
TRCNF
PRABHHANS
KESKBH
YU
LALPATHLAB
ZLIOY